Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...
CBSE has announced the schedule and issued detailed guidelines for Class 10 and 12 practical exams, project work, and ...